Overview

A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma

Status:
Completed

Trial end date:
2016-05-01

Target enrollment:

Participant gender:

Summary

This study is a double-blind, randomized, placebo-controlled, 2-period, crossover study to evaluate safety and PK of 3 doses of CVT 301 levodopa (l-dopa) in adults with asthma.

Phase:

Phase 1

Details

Lead Sponsor:

Acorda Therapeutics

Treatments:

Carbidopa
Levodopa